ArticleScience in One Health2026
Mapping the scientific landscape of Lassa virus: a 55-year bibliometric study (1970-2025).
Article in Science in One Health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends, Gaps, and Challenges in Antiviral Resistance: A Bibliometric Analysis and Narrative Synthesis of Key Viruses, Resistance Mechanisms, and Drivers.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lassa fever is a zoonotic disease, caused by Lassa virus (LASV), that was first reported in 1965. After 55 years, its research landscape remains largely underexplored. Therefore, a bibliometric study is needed to identify LASV research landscape. Methods: Scopus database was searched and the resulting data was analyzed using VOSviewer (version 1.6.15) for Windows, bibliometrix (version 3.0.0) with Biblioshiny, and R (version 4.5.2) to reveal trends in LASV publications, including keywords, authors' productivity over time, and collaboration among research institutions and universities. Results: From Scopus, 1566 studies were retrieved, and the trend analysis indicated three distinct phases: a low productivity phase (1970-2002), consistent increase phase (2003-2014), and high productivity phase (2015-2025). Conclusion: Despite significant growth in LASV research, critical gaps in vaccines, therapeutics, and endemic region representation highlight the urgent need for locally driven One Health studies and equitable research partnerships.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.